News

SA hospital system’s nonprofit owner taps new CEO with close ties

Jaime Wesolowski is putting off retirement to become the new CEO of Methodist Healthcare Ministries of ...

StemBioSys CEO: Company has room to grow in San Antonio

Bob Hutchens is CEO of StemBioSys Inc. CARLOS JAVIER SANCHEZ | SABJ By W. Scott Bailey – Senior ...

Events

Medical Devices 101: An Educational Forum

When:  8:00 – 5:00 pm Monday, August 13 Where:  Norris Conference Center, ...
News
San Antonio's Health Science Center names executive in charge of research
May 4, 2015

The University of Texas Health Science Center at San Antonio has appointed Andrea Giuffrida vice president of research. (Courtesy of Lester Rosebrock/Health Science Center)

By W. Scott Bailey, San Antonio Business Journal

The University of Texas Health Science Center at San Antonio has appointed Andrea Giuffrida vice president for research. He had served as interim vice president since May 2014.

Health Science Center President Dr. William Henrich said Giuffrida has already made a significant contribution, helping align resources and secure funding, including a grant renewal to fund the Voelcker Biomedical Research Academy.

Giuffrida has also helped negotiate the acquisition of new instrumentation for an Electron Microscopy Facility and Optical Imaging Core, and also prioritized future research investment needs.

Giuffrida, an associate professor of pharmacology, previously served as the director of biomedical research development in the Office of the Vice President for Research at the Health Science Center. He is an experienced investigator and educator who joined the School of Medicine and Graduate School of Biomedical Sciences faculty in 2003.

Health Science Center officials said Giuffrida's research focuses on endocannabinoids, a family of naturally occurring lipids that mimic the effect of marijuana. His work has provided important breakthroughs in the neurobiology of the endocannabinoid system and its role in neurological and psychiatric disorders, including Parkinson's disease and schizophrenia.

Giuffrida's research has been supported by funding from the National Institutes of Health, National Science Foundation and a number of private organizations, including the M.J. Fox Foundation and the Brain & Behavior Research Foundation.

 

Stay informed. Subscribe to BioMed SA news alerts.